Beamtree HoldingsASX:BMT 28 Buyback Yield % is -0.03 as of Jul. 11, 2026. GuruFocus rates ASX:BMT with a GF Score™ of 28/100 and a GF Value™ of A$0.54 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 276 Healthcare Providers & Services companies, Beamtree Holdings ranks better than 50.72% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Beamtree Holdings's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:BMT vs VEEV, BTSG, TEM: Buyback Yield % Comparison
For the Health Information Services subindustry, Beamtree Holdings's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beamtree Holdings Buyback Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Beamtree Holdings's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Beamtree Holdings's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beamtree Holdings (ASX:BMT) has a Buyback Yield % of -0.03 as of Jul. 11, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Beamtree Holdings and its competitors. According to the industry distribution chart, Beamtree Holdings ranks #136 out of 276 companies in the Healthcare Providers & Services industry, placing it in the top 49.3%.
Is Beamtree Holdings' Buyback Yield % too high?
Beamtree Holdings' current Buyback Yield % is -0.03. Based on the distribution chart, Beamtree Holdings ranks #136 out of 276 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Beamtree Holdings has a GF Score™ of 28/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Beamtree Holdings' Buyback Yield % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Beamtree Holdings ranks #136 out of 276 companies for Buyback Yield %. This puts Beamtree Holdings in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Healthcare Providers & Services company?
A good Buyback Yield % depends on the Healthcare Providers & Services industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Beamtree Holdings and its competitors. Beamtree Holdings's current Buyback Yield % is -0.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beamtree Holdings stock overvalued right now?
Based on GuruFocus' analysis, Beamtree Holdings (ASX:BMT) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.54, compared to a current price of A$0.13 — trading 75.9% below its estimated fair value. The current Buyback Yield % is -0.03. Beamtree Holdings' overall GF Score™ is 28/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Beamtree Holdings (ASX:BMT), the current Buyback Yield % is -0.03 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beamtree Holdings (ASX:BMT) Overvalued in 2026?
Based on GuruFocus' analysis, Beamtree Holdings stock appears to be undervalued.
The current stock price of A$0.13 is trading 75.9% below its estimated GF Value™ of A$0.54.
GuruFocus considers Beamtree Holdings to be Possible Value Trap.
Key valuation signals for ASX:BMT:
Buyback Yield %: -0.03
GF Value™: A$0.54 vs. price of A$0.13 (75.9% below fair value)
No single metric tells the full story. See the ASX:BMT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beamtree Holdings Ltd is an Artificial intelligence (AI) health technology company. It offers software solutions like Picq, RippleDown, Risq, Ainsoff, Q Coding platform, and others across four product segments that combine into a modular software suite to assist healthcare services in transforming the quality of their data, analyzing key performance insights, and improving actionable decision support. The company's key operating product segments are: Knowledge Networks, which generate maximum revenue, Diagnostics, Clinical Decision Support, and Coding and Data Quality Assurance. Geographically, it operates in Australia, its key revenue-generating market, Europe, and the Rest of the world.
28GF Score
Get the complete analysis for ASX:BMT
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:BMT has been successfully added to your 
